検索条件
MHC Allele - A*02:01
クリップ | Code No. | 品名 | データ | ||||
---|---|---|---|---|---|---|---|
データ
シート |
項目 | 標識 | MHC Allele | 包装 | 価格 | 在庫 | |
配列 | 位置 | 温度 | |||||
|
|||||||
TB-M076-2 |
HLA-A*02:01 MAGE-A3 271-279 Tetramer-FLWGPRALV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLWGPRALV | 271-279 | 4°C | |||||
TB-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLAGGFFLL | 27-38 | 4°C | |||||
TS-M079-2 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KASEKIFYV | 41-49 | 4°C | |||||
TS-M083-1 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KLQDASAEV | 126-134 | 4°C | |||||
TB-0122-2 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-APC |
||||||
virus HBV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLLTRILTI | 4°C | ||||||
TB-0120-1 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLEPGPVTV | 4°C | ||||||
TB-0113-4 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLFFYRKSV | 4°C | ||||||
TB-0107-1 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-PE |
||||||
Others | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LNIDLLWSV | 4°C | ||||||
TB-M039-2 |
HLA-A*02:01 HCV NS31073-1081 Tetramer-CINGVCWTV-APC |
||||||
virus HCV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
CINGVCWTV | 1073-1081 | 4°C | |||||
TB-0017-4 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLQELNVTV | 169-177 | 4°C | |||||
TB-0010-4 |
T-Select HLA-A*02:01 CMV pp65 Tetramer-NLVPMVATV-BV421 |
||||||
virus CMV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
NLVPMVATV | 495-503 | 4°C | |||||
TB-0157-2 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RMPEAAPPV | 65-73 | 4°C | |||||
TS-M019-1 |
T-Select HLA-A*02:01 HTLV-1 Tax178-186 Tetramer-QLGAFLTNV-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
QLGAFLTNV | 178-186 | 4°C | |||||
TS-M093-2 |
HLA-A*02:01 HA-1 Tetramer-VLHDDLLEA-APC |
||||||
Others | APC | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
VLHDDLLEA | 137-145 | 4°C | |||||
TB-M051-2 |
HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
WLSLLVPFV | 335-343 | 4°C | |||||
TB-M053-2 |
HLA-A*02:01 HBV pol Tetramer-FLLSLGIHL-APC |
||||||
virus HBV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLLSLGIHL | 575-583 | 4°C | |||||
TB-0107-2 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-APC |
||||||
Others | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LNIDLLWSV | 4°C | ||||||
TB-0014-4 |
T-Select HLA-A*02:01 gp100 (Wild) Tetramer-ITDQVPFSV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ITDQVPFSV | 209-217 | 4°C | |||||
TB-0133-4 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-BV421 |
||||||
virus HTLV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AVLDGLLSL | 42-50 | 4°C | |||||
TB-0165-4 |
HLA-A*02:01 Influenza M1 Tetramer-ILGFVFTLTV-BV421 |
||||||
virus Influenza |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ILGFVFTLTV | 4°C | ||||||
TB-0110-1 |
HLA-A*02:01 Mesothelin Tetramer-SLLFLLFSL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLFLLFSL | 4°C | ||||||
TB-0011-4 |
T-Select HLA-A*02:01 EBV BMLF1 Tetramer-GLCTLVAML-BV421 |
||||||
virus EBV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLCTLVAML | 280-288 | 4°C | |||||
TS-M081-1 |
HLA-A*02:01 p53 Tetramer-LLGRNSFEV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
LLGRNSFEV | 264-272 | 4°C | |||||
TB-0113-1 |
HLA-A*02:01 hTERT Tetramer-YLFFYRKSV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLFFYRKSV | 4°C | ||||||
TB-M057-2 |
HLA-A*02:01 CMV IE1316-324 Tetramer-VLEETSVML-APC |
||||||
virus CMV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLEETSVML | 316-324 | 4°C | |||||
TB-0035-4 |
T-Select HLA-A*02:01 gp100 154-162 Tetarmer-KTWGQYWQV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KTWGQYWQV | 154-162 | 4°C | |||||
TB-0019-4 |
T-Select HLA-A*02:01 Tyrosinase Tetramer-YMDGTMSQV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YMDGTMSQV | 368-376 | 4°C | |||||
TB-0015-4 |
T-Select HLA-A*02:01 Her-2/neu E75 Tetramer-KIFGSLAFL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KIFGSLAFL | 369-377 | 4°C | |||||
TB-0170-2 |
HLA-A*02:01 IAPP Tetramer-KLQVFLIVL-APC |
||||||
Others | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLQVFLIVL | 5-13 | 4°C | |||||
TB-0162-4 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-BV421 |
||||||
Others | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLFGLGFAI | 265-273 | 4°C | |||||
TB-0162-2 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-APC |
||||||
Others | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLFGLGFAI | 265-273 | 4°C | |||||
TB-0135-4 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-BV421 |
||||||
virus HIV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLADQLIHL | 101-109 | 4°C | |||||
TB-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AILALLPAL | 105-133 | 4°C | |||||
TS-M094-2 |
HLA-A*02:01 H-Y Tetramer-FIDSYICQV-APC |
||||||
Others | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
FIDSYICQV | 311-319 | 4°C | |||||
TB-M120-1 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLTPKKLQCV | 141-150 | 4°C | |||||
TB-M039-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CINGVCWTV-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
CINGVCWTV | 1073-1081 | 4°C | |||||
TB-0122-1 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-PE |
||||||
virus HBV |
PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLLTRILTI | 4°C | ||||||
TB-0118-1 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CVNGVCWTV-PE |
||||||
virus HCV |
PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
CVNGVCWTV | 4°C | ||||||
TB-0102-4 |
HLA-A*02:01 Insulin B Tetramer-HLVEALYLV-BV421 |
||||||
Others | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
HLVEALYLV | 4°C | ||||||
TB-M105-4 |
HLA-A*02:01 NY-ESO-1 C9V Tetramer-SLLMWITQV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLMWITQV | 157-165 | 4°C | |||||
TB-0017-1 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLQELNVTV | 169-177 | 4°C | |||||
TB-0016-4 |
T-Select HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLLQETELV | 689-697 | 4°C | |||||
TB-0155-1 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLFLGILSV | 188-196 | 4°C | |||||
TB-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLQHWVPEL | 97-106 | 4°C | |||||
TB-0146-4 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-BV421 |
||||||
virus EBV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLLEMLWRL | 125-133 | 4°C | |||||
TS-M043-1 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVSKL-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ALYDVVSKL | 2594-2602 | 4°C | |||||
TS-M043-2 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVSKL-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
ALYDVVSKL | 2594-2602 | 4°C | |||||
TS-M061-2 |
HLA-A*02:01 AdV Hexon 917-925 Tetramer-YVLFEVFDV-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
YVLFEVFDV | 917-925 | 4°C | |||||
TS-M083-2 |
HLA-A*02:01 HM1.24 Tetramer-KLQDASAEV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KLQDASAEV | 126-134 | 4°C | |||||
TS-M097-1 |
HLA-A*02:01 BTG1 Tetramer-TLWVDPYEV-PE |
||||||
Others | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TLWVDPYEV | 103-111 | 4°C | |||||
TB-M040-1 |
HLA-A*02:01 HCV NS3 1406-1415 Tetramer-KLVALGINAV-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLVALGINAV | 1406-1415 | 4°C | |||||
TB-0122-4 |
HLA-A*02:01 HBV S protein Tetramer-FLLTRILTI-BV421 |
||||||
virus HBV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLLTRILTI | 4°C | ||||||
TB-0121-2 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-APC |
||||||
virus LCMV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALPHIIDEV | 4°C | ||||||
TB-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLEPGPVTV | 4°C | ||||||
TB-0118-4 |
HLA-A*02:01 HCV NS3 1073-1081 Tetramer-CVNGVCWTV-BV421 |
||||||
virus HCV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
CVNGVCWTV | 4°C | ||||||
TB-0013-4 |
T-Select HLA-A*02:01 gp100 (mutant) Tetramer-IMDQVPFSV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
IMDQVPFSV | 209-217 | 4°C | |||||
TB-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLPPPGTRV | 149-157 | 4°C | |||||
TB-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLFLGILSV | 188-196 | 4°C | |||||
TB-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
QLCPICRAPV | 175-184 | 4°C | |||||
TB-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLCPVQLWV | 139-147 | 4°C | |||||
TB-0151-2 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLQHWVPEL | 97-106 | 4°C | |||||
TB-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLAPPQHLIRV | 187-197 | 4°C | |||||
TB-0133-2 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-APC |
||||||
virus HTLV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AVLDGLLSL | 42-50 | 4°C | |||||
TB-0127-1 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AILALLPAL | 105-133 | 4°C | |||||
TS-M041-1 |
HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
VLSDFKTWL | 1992-2000 | 4°C | |||||
TS-M078-2 |
HLA-A*02:01 MAGE-A10 Tetramer-GLYDGMEHL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
GLYDGMEHL | 254-262 | 4°C | |||||
TS-M079-1 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
KASEKIFYV | 41-49 | 4°C | |||||
TS-M084-1 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TLADFDPRV | 883-891 | 4°C | |||||
TS-M098-1 |
HLA-A*02:01 HA-8 Tetramer-RTLDKVLEV-PE |
||||||
Others | PE | A*02:01 | 50 tests | ¥209,000 | 1-9 | ||
RTLDKVLEV | 149-157 | 4°C | |||||
TB-0013-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (IMDQVPFSV) |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
IMDQVPFSV | 209-217 | 4°C | |||||
TB-M082-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTA-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLEPGPVTA | 280-288 | 4°C | |||||
TB-M075-2 |
HLA-A*02:01 MAGE-A3 112-120 Tetramer-KVAELVHFL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KVAELVHFL | 112-120 | 4°C | |||||
TB-0154-2 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LMWYELSKI | 4°C | ||||||
TB-0121-4 |
HLA-A*02:01 LCMV ND Tetramer-ALPHIIDEV-BV421 |
||||||
virus LCMV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALPHIIDEV | 4°C | ||||||
TB-0116-4 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-BV421 |
||||||
virus LCMV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLVSIFLHL | 4°C | ||||||
TB-0107-4 |
HLA-A*02:01 IGRP Tetramer-LNIDLLWSV-BV421 |
||||||
Others | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LNIDLLWSV | 4°C | ||||||
TB-0017-2 |
T-Select HLA-A*02:01 PR-1 Tetramer-VLQELNVTV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLQELNVTV | 169-177 | 4°C | |||||
TB-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GVRGRVEEI | bcr-abl fusion protein | 4°C | |||||
TB-0158-1 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLFLGILSV | 188-196 | 4°C | |||||
TB-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLLGASVLGL | 674-683 | 4°C | |||||
TB-0146-2 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-APC |
||||||
virus EBV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLLEMLWRL | 125-133 | 4°C | |||||
TB-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLAPPQHLIRV | 187-197 | 4°C | |||||
TB-0135-2 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-APC |
||||||
virus HIV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLADQLIHL | 101-109 | 4°C | |||||
TB-0134-4 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FVGEFFTDV | 144-152 | 4°C | |||||
TB-0132-4 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLYDDNQRV | 828-836 | 4°C | |||||
TS-M041-2 |
HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
VLSDFKTWL | 1992-2000 | 4°C | |||||
TS-M084-2 |
HLA-A*02:01 EphA2 Tetramer-TLADFDPRV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥209,000 |
0 (お問合せ) |
||
TLADFDPRV | 883-891 | 4°C | |||||
TB-M051-1 |
HLA-A*02:01 HBV env 335-343 Tetramer-WLSLLVPFV-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
WLSLLVPFV | 335-343 | 4°C | |||||
TB-0154-1 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LMWYELSKI | 4°C | ||||||
TB-0120-2 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLEPGPVTV | 4°C | ||||||
TB-0114-4 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLQVNSLQTV | 4°C | ||||||
TB-0112-1 |
HLA-A*02:01 Mesothelin Tetramer-VLPLTVAEV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLPLTVAEV | 4°C | ||||||
TB-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0170-4 |
HLA-A*02:01 IAPP Tetramer-KLQVFLIVL-BV421 |
||||||
Others | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLQVFLIVL | 5-13 | 4°C | |||||
TB-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLGSYGFRL | 103-111 | 4°C | |||||
TB-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
QLCPICRAPV | 175-184 | 4°C | |||||
TB-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLCPVQLWV | 139-147 | 4°C | |||||
TB-0135-1 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-PE |
||||||
virus HIV |
PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLADQLIHL | 101-109 | 4°C |
※在庫につきましては2024年04月26日 17時00分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、
キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について: RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。